SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B4 - Prospectus [Rule 424(b)(4)]:
SEC Accession No. 0001104659-21-020657
Filing Date
2021-02-11
Accepted
2021-02-11 16:01:02
Documents
11

Document Format Files

Seq Description Document Type Size
1 424B4 tm2030737-12_424b4.htm 424B4 2362307
2 GRAPHIC lg_vallonpharma-4c.jpg GRAPHIC 187841
3 GRAPHIC tm2030737d1-cov_vallon4clr.jpg GRAPHIC 524229
4 GRAPHIC tm2030737d1-tbl_pipe4clr.jpg GRAPHIC 171333
5 GRAPHIC tm2030737d1-icon_arrowbw.jpg GRAPHIC 2676
6 GRAPHIC tm2030737d1-lc_methyl4c.jpg GRAPHIC 283250
7 GRAPHIC tm2030737d1-bc_method4c.jpg GRAPHIC 229918
8 GRAPHIC tm2030737d1-bc_rate4c.jpg GRAPHIC 247939
9 GRAPHIC tm2030737d1-ph_adair4clr.jpg GRAPHIC 513509
10 GRAPHIC tm2030737d1-ph_multiple4c.jpg GRAPHIC 284813
11 GRAPHIC tm2030737d1-ph_viscos4clr.jpg GRAPHIC 296948
  Complete submission text file 0001104659-21-020657.txt   6140114
Mailing Address TWO LOGAN SQUARE 100 N. 18TH STREET, SUITE 300 PHILADELPHIA PA 19103
Business Address TWO LOGAN SQUARE 100 N. 18TH STREET, SUITE 300 PHILADELPHIA PA 19103 (267) 207-3606
Vallon Pharmaceuticals, Inc. (Filer) CIK: 0001824293 (see all company filings)

IRS No.: 824369909 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B4 | Act: 33 | File No.: 333-249636 | Film No.: 21619483
SIC: 2834 Pharmaceutical Preparations